CVE-2015-3965 json
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elev…
published 2019-03-23 7 y ago modified 2026-06-17 4 mo ago also EUVD-2015-3996
- cvss
- 8.8
- version 3.0, NVD
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 2.9%
- EPSS 2.9% chance of exploitation in 30 days, percentile 86%
- public exploits
- 0
- none known
Summary
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Vendor advisories
What the vendors themselves say about their products: affected, fixed or not affected, and what to do.
cisa ICSA-15-174-01 updated cvss 7.1
Hospira Symbiq Infusion System Vulnerability
-
Hospira Symbiq Infusion System <=3.13affected: mitigation
From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf
Exploit prediction
2.88% chance of exploitation in the next 30 days, higher than 86% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| NVD | 3.0 | 8.8 | CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
| NVD | 2.0 | 9.0 | AV:N/AC:L/Au:S/C:C/I:C/A:C |
Affected products
- Hospira Symbiq Infusion System
Classification
- Weakness
-
- CWE-264 Permissions, Privileges, and Access Controls
References
-
ics-cert.us-cert.gov
/advisories/ICSA-15-174-01
third-party-advisory, us-government-resource
Sources
- CVE List CVE-2015-3965
- NVD CVE-2015-3965
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.